2024 Scott Mid-Market Benefits Benchmarking & RX-GLP-1 Medications Workshop

About the Event

Join us for a comprehensive review of the results from our 2024 benefits benchmarking survey, the largest of its kind in the region and the nation. Discover how your benefit program compares to those of peer organizations and receive real-time guidance from our actuarial team. Additionally, we will discuss the current and future health and safety risks associated with GLP-1 medications for type 2 diabetes and weight loss in employer-sponsored health insurance plans, as well as the financial challenges organizations face with the rising costs of GLP-1 medications.